Expression and subcellular localization of P9-ZFD protein in patients with myasthenia gravis

Chinese Medical Sciences Journal

Volumn 19, Issue 3, 2004, Pages 221-224

  Ren, Ming Shan ^a   Lu, Chuan Zhen ^a   Qiao, Jian ^a   Ren, Hui Min ^a   Xu, Ren ^b   Gan, Ren Bao ^b  

^a FUDAN UNIVERSITY   (China)

^b INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

Myasthenia gravis; P9 ZFD gene fragment; Skeletal muscle

Indexed keywords

PROTEIN P9 ZFD; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ADULT; ARTICLE; CASE REPORT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOELECTRON MICROSCOPY; IMMUNOHISTOCHEMISTRY; MYASTHENIA GRAVIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE;

ADULT; CELL MEMBRANE; ESCHERICHIA COLI; FEMALE; HUMANS; MUSCLE PROTEINS; MUSCLE, SKELETAL; MYASTHENIA GRAVIS; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; TRANSFECTION; ZINC FINGERS;

EID: 5444247105     PISSN: 10019294     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Angela V, John M, Maria EF, et al. Antibodies in myasthenia gravis and related disorders. Ann NY Acad Sci 2003;998:324-35.
2. Angela V, Jackie P, David HJ. Myasthenia gravis. Lancet 2001;357:2122-6.
3. Ren HM, Lu CZ, Zhou ZG, et al. Analysis of 25 kD protein content of skeletal muscles from the patients with myasthenia gravis. Chin J Neurol 2002;35:32-4.
4. Liyanage Y, Hoch W, Beeson D, et al. The agrin/muscle-specific kinase pathway: new targets for autoimmune and genetic disorders at the neuromuscular junction. Muscle Nerve 2002;25:4-16.
5. Wu YQ, Lu CZ, Zhou TH, et al. Screening and identification of genes related to myasthenia gravis by differential display polymerase chain reaction. J Chin Neurol 1998;31:69-71.
6. Zhou ZG, Lu JH, Ren HM, et al. Study on distribution of MG related differential gene segments P2 and P9. Natl Med J China 2000;80:760-1.
7. Marguerite H. The neuromuscular junction disorders. J Neurol Neurosurg Psychiatry 2003;74:32-7.
8. Wolfe GI. Clinical evaluation and diagnostic tests for neuromuscular disorders. Arch Neurol 2003;60:1487.
9. Amelia E, Pietro AT, Luca P, et al. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 2003;126:2304-11.
10. Hoch W, Mc Conville J, Helms S, et al. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 2001;7:365-9.
11. Bradley JR, Pober JS. Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 2001;20:6482-91.